Home Compare AMGN vs COLO-B.CO
Stock Comparison · Comparison

Amgen vs Coloplast A/S: Which Stock Looks Stronger in 2026?

Amgen holds the cleaner structural position, with growth as the main driver and valuation adding further support. The market setup broadly confirms the structural lead — Amgen holds the more constructive position. That puts structure and market broadly in agreement — Amgen's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in growth, but valuation adds another real layer to the result. Amgen Inc. leads by 10 points on the overall comparison score.

Trajectory Similarity
0.64
Moderately similar
Peer-set rank: #5
within Amgen Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The clearest structural overlap shows up in revenue growth trajectory and operating margin level.

Similarity drivers
revenue growth trajectoryoperating margin level
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
AMGN
Amgen Inc.
63
Peer-Score
Signal qualityHigh
vs
COLO-B.CO
Coloplast A/S
53
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: AMGN vs COLO-B.CO Profitability 50 57 Stability 57 56 Valuation 73 54 Growth 75 44 AMGN COLO-B.CO
Gap Ranking
#1 Growth +31
#2 Valuation +19
#3 Profitability +7
#4 Stability +1
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AMGN and COLO-B.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AMGNCOLO-B.CO Relative valuation Structural strength

Amgen Inc. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Both rank well on growth, but Amgen Inc. still holds a clear edge.
Valuation
On valuation, the edge still sits with Amgen Inc., even though both profiles look solid.
Growth — Dominant Gap
AMGN
75
COLO-B.CO
44
Gap+31in favour of AMGN

Earnings growth is one contributing factor within the growth lead.

What else supports the lead

Valuation adds another layer of support rather than leaving the result tied to growth alone.

What this means for the comparison

Growth is the clearest driver, and valuation also supports Amgen Inc.'s broader structural position.

Explore full peer positioning in AssetNext

Break down the AMGN vs COLO-B.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-valuation comparisons

Explore how AMGN and COLO-B.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.